Conventional and sustained-release valproate in children with newly diagnosed epilepsy: a randomized and crossover study comparing clinical effects, patient preference and pharmacokinetics
Authors:
- 2 August 2006
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 62 (10) , 805-815
Abstract
It has been suggested that sustained-release valproate (VPA) formulations may be more effective and better tolerated than conventional VPA due to better compliance and lower fluctuations in VPA serum concentrations, but comparative trials with conventional VPA in children are scarce. This randomized and crossover trial compared the efficacy (complete control of seizures), the tolerability, and the patient (or parents) preference of conventional VPA twice daily (CVbid) with those of sustained-release chrono VPA twice daily (ChVbid), once daily in the morning (ChVom) or once daily in the evening (ChVoe) in monotherapy.Keywords
This publication has 22 references indexed in Scilit:
- Computerized Tremor Analysis of Valproate‐induced Tremor: A Comparative Study of Controlled‐release versus Conventional ValproateEpilepsia, 2005
- A Retrospective Study of 113 Epileptic Patients Treated with Sustained-Release ValproateEpilepsia, 1994
- Valproic AcidDrugs, 1994
- Conventional and controlled release valproate in children with epilepsy: a cross-over study comparing plasma levels and cognitive performancesEpilepsy Research, 1992
- A comparative clinical and pharmacokinetic study of a new slow-release versus conventional preparations of valproic acid in children with intractable epilepsyBrain and Development, 1992
- Pharmacokinetic Evaluation of Sustained Release Formulations of Antiepileptic DrugsClinical Pharmacokinetics, 1992
- Concentration-Effect Relationships of Valproic AcidClinical Pharmacokinetics, 1985
- Intensive Follow-up Monitoring in Patients with Once Daily Evening Administration of Sodium ValproateEpilepsia, 1984
- Monodose versus 3 daily doses of sodium valproate: a controlled trialActa Neurologica Scandinavica, 1984
- Once‐daily Sodium Valproate in the Treatment of EpilepsyDevelopmental Medicine & Child Neurology, 1980